Stay updated on Pembrolizumab in Medullary Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Medullary Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Medullary Thyroid Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added a Medullary thyroid carcinoma topic entry and a Resources section linking to the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-04-02T06:59:01.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T21:20:12.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T18:04:00.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 tag was added and the previous Revision: v3.4.1 tag was removed; no study content, eligibility criteria, or navigation changes are evident.
    Difference
    0.4%
    Check dated 2026-02-11T02:20:17.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding lapse and NIH Clinical Center status, and updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-03T23:13:26.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Glossary is now shown on the page, and the revision metadata has been updated to v3.4.0. New metadata entries 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' were added, while the previous 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.
    Difference
    0.2%
    Check dated 2026-01-27T23:49:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Medullary Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Medullary Thyroid Cancer Clinical Trial page.